Home › Trial NCT07831772
REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
- Trial IDNCT07831772
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Minnesota
- Enrollment4
- Start date2026-08-24
- ConditionsGlioblastoma · Newly Diagnosed Glioblastoma · Brain Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.